Cooley advised the Boston Celtics and the Grousbeck family, while Wachtell, Lipton, Rosen & Katz served as legal counsel to Chisholm and his investor group on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Homburger advised Taiho Pharmaceutical on the transaction, while Cooley, BGPartner Ltd and Baker McKenzie advised Araris Biotech. Taiho Pharmaceutical Co.,...
You must be a Standard 1 Year member to access this content.
Cooley advised Vivace Therapeutics, Inc., and Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics on the patent matters related to the transaction. Vivace Therapeutics, Inc. announced...
You must be a Standard 1 Year member to access this content.
Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Jazz, while Skadden and Cooley are advising Chimerix on the deal. Jazz Pharmaceuticals plc and...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised Upbound Group, Cooley and Mayer Brown advised Brigit on the transaction. Upbound Group, a technology and data-driven leader in accessible and inclusive...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction, and Cooley advised Accolade. Transcarent, the “One Place for Health and Care,” and Accolade, a leader...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Cooley advised Veritone, DLA Piper advised Insignia Capital Group, and Sheppard Mullin advised Oxford Road on the deal. Oxford Road and Veritone One, two leading audio...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
You must be a Standard 1 Year member to access this content.
